However, in a two-year double-blinded RCT of high-dose oral vitamin D 3 supplementation (20,000 IU/week) in another cohort of 68 patients with RRMS with lower disease activity we found only a strong trend for a reduction among patients without DMTs and no overall effect of increasing serum 25(OH)D levels on serum levels of NfL ( 10 ).
← all excerpts
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis.
1
—
—